当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 现金流量表

特一药业

(002728)

  

流通市值:31.57亿  总市值:48.82亿
流通股本:3.32亿   总股本:5.13亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金205,543,757.02982,118,788.89763,287,771.48570,257,085.16
  收到的税费返还-3,116,430.55--
  收到其他与经营活动有关的现金2,822,691.238,506,168.566,550,502.693,137,823.42
  经营活动现金流入小计208,366,448.25993,741,388769,838,274.17573,394,908.58
  购买商品、接受劳务支付的现金65,400,700.02231,852,321.31183,726,560.5135,528,055.08
  支付给职工以及为职工支付的现金34,161,178.09114,578,720.7685,500,588.1757,316,779
  支付的各项税费20,125,433.2791,280,757.5358,972,603.0849,723,211.01
  支付其他与经营活动有关的现金77,003,958.3311,941,045.21250,445,074.91184,620,532.13
  经营活动现金流出小计196,691,269.68749,652,844.81578,644,826.66427,188,577.22
  经营活动产生的现金流量净额11,675,178.57244,088,543.19191,193,447.51146,206,331.36
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,398,476.22795,560.28748,710.96299,726.03
  处置固定资产、无形资产和其他长期资产收回的现金净额800200,800200,000200,000
  收到的其他与投资活动有关的现金299,998,000195,000,000185,000,000110,000,000
  投资活动现金流入小计301,397,276.22195,996,360.28185,948,710.96110,499,726.03
  购建固定资产、无形资产和其他长期资产支付的现金13,448,694.9479,547,293.7955,854,596.8837,445,391.99
  支付其他与投资活动有关的现金314,998,000405,000,000285,000,000185,000,000
  投资活动现金流出小计328,446,694.94484,547,293.79340,854,596.88222,445,391.99
  投资活动产生的现金流量净额-27,049,418.72-288,550,933.51-154,905,885.92-111,945,665.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金-15,436,169.0513,725,358.8611,086,308.48
  取得借款收到的现金80,000,000618,950,602.65420,000,000310,000,000
  收到其他与筹资活动有关的现金-184,000,000154,000,000154,000,000
  筹资活动现金流入小计80,000,000818,386,771.7587,725,358.86475,086,308.48
  偿还债务支付的现金50,000,000889,000,000677,000,000517,000,000
  分配股利、利润或偿付利息支付的现金405,704.224,913,403.9927,692,820.32,167,198.56
  支付其他与筹资活动有关的现金-37,336,006.4737,336,006.477,336,006.47
  筹资活动现金流出小计50,405,704.2951,249,410.46742,028,826.77526,503,205.03
  筹资活动产生的现金流量净额29,594,295.8-132,862,638.76-154,303,467.91-51,416,896.55
五、现金及现金等价物净增加额14,220,055.65-177,325,029.08-118,015,906.32-17,156,231.15
  加:期初现金及现金等价物余额125,636,694.41302,961,723.49302,961,723.49302,961,723.49
  期末现金及现金等价物余额139,856,750.06125,636,694.41184,945,817.17285,805,492.34
补充资料:
  净利润-81,671,615.4-38,007,729.88
  资产减值准备--305,798.2--2,302,376.77
  固定资产和投资性房地产折旧-56,271,060.28-28,268,607.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-56,271,060.28-28,268,607.64
  无形资产摊销-13,549,376.71-6,426,240.19
  处置固定资产、无形资产和其他长期资产的损失-68,451.01-83,374.88
  固定资产报废损失-818,804.44--
  财务费用-3,770,236.12-3,073,825.93
  投资损失--795,560.28--299,726.03
  递延所得税--7,914,019.29-2,993,489.38
  其中:递延所得税资产减少--6,916,229.01-3,139,353.84
    递延所得税负债增加--997,790.28--145,864.46
  存货的减少-25,090,917.51--21,827,924.9
  经营性应收项目的减少-45,813,227.51-66,936,115.77
  经营性应付项目的增加-25,885,218.28-24,846,975.39
  其他-165,013.7--
  现金的期末余额-125,636,694.41-285,805,492.34
  减:现金的期初余额-302,961,723.49-302,961,723.49
  现金及现金等价物的净增加额--177,325,029.08--17,156,231.15
公告日期2026-04-282026-03-242025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑